These effects, together with a earlier report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two assist the thought of targeting ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-relevant disorders.These benefits propose that conolidine is able